Design of Inhibitors for S100B

Author(s): Joseph Markowitz, Alexander D. MacKerell Jr., France Carrier, Thomas H. Charpentier, David J. Weber

Journal Name: Current Topics in Medicinal Chemistry

Volume 5 , Issue 12 , 2005

Become EABM
Become Reviewer


S100B interacts with the p53 protein in a calcium-dependent manner and down-regulates its function as a tumor suppressor. Therefore, inhibiting the S100B-p53 interaction represents a new approach for restoring functional wild-type p53 in cancers with elevated S100B such as found in malignant melanoma. A discussion of the biological rational for targeting S100B and a description of methodologies relevant to the discovery of compounds that inhibit S100B-p53 binding, including computational techniques, structural biology techniques, and cellular assays, is presented.

Keywords: melanoma, p53 tumor suppressor protein, cyclin-dependent kinase inhibitor, epitope mapping, computer-aided drug design, fluorescence spectroscopy, std-nmr

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [1093 - 1108]
Pages: 16
DOI: 10.2174/156802605774370865
Price: $65

Article Metrics

PDF: 4